Literature DB >> 22475845

Exposure to supernatants of macrophages that phagocytized dead mesenchymal stem cells improves hypoxic cardiomyocytes survival.

Wenbin Lu1, Cong Fu, Li Song, Yuyu Yao, XiaoLi Zhang, Zhong Chen, Yongjun Li, Genshan Ma, Chengxing Shen.   

Abstract

OBJECTIVE: To observe the impact of supernatants from macrophages that phagocytized dead MSCs (pMΦ) on the survival of hypoxic cardiomyocytes.
METHODS: MSCs were isolated from bone marrow of mice and dead MSCs were harvested after 6h hypoxia. Macrophages were obtained from thioglycolate-elicited peritoneal cavity. Macrophages and dead MSCs were co-cultured for 2 days in the presence or absence of LPS (1 μg/ml). Cardiomyocytes obtained from neonatal mice were exposed to various medium including supernatants from pMΦ. MTT cell proliferation assay and mitochondria membrane potential were used to evaluate the viability of cardiomyocytes. Cytokines and chemokines (TNF-α, IFN-γ, IL-6, IL-12, PGE2, VEGF-α, Ang-1, KGF, IGF-1, PDGF-BB, and EPO) in culture medium of macrophages, MSCs and pMΦ were detected by ELISA and Real-Time-PCR.
RESULTS: phagocytic activity of macrophages to dMSC was significantly enhanced by LPS. PGE2, VEGF-α, Ang-1, KGF, IGF-1, PDGF-BB, and EPO levels were significantly increased in supernatants of pMΦ. Exposure to supernatants of pMΦ significantly improved viability and survival time of hypoxic cardiomyocytes.
CONCLUSION: Exposure to supernatants of pMΦ significantly improved viability and survival time of hypoxic cardiomyocytes, which might be linked to increased cytokines and chemokines secretion by pMΦ.
Copyright © 2012 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22475845     DOI: 10.1016/j.ijcard.2012.03.088

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  28 in total

Review 1.  Current understanding of the immunosuppressive properties of mesenchymal stromal cells.

Authors:  Ligia Lins de Castro; Miquéias Lopes-Pacheco; Daniel Jay Weiss; Fernanda Ferreira Cruz; Patricia Rieken Macêdo Rocco
Journal:  J Mol Med (Berl)       Date:  2019-03-22       Impact factor: 4.599

2.  Therapeutic implications of transplanted-cell death.

Authors:  Zachary W Wagoner; Weian Zhao
Journal:  Nat Biomed Eng       Date:  2021-05       Impact factor: 25.671

3.  Macrophage Subpopulation Dynamics Shift following Intravenous Infusion of Mesenchymal Stromal Cells.

Authors:  Nina Kosaric; Waracharee Srifa; Clark A Bonham; Harriet Kiwanuka; Kellen Chen; Britta A Kuehlmann; Zeshaan N Maan; Chikage Noishiki; Matthew H Porteus; Michael T Longaker; Geoffrey C Gurtner
Journal:  Mol Ther       Date:  2020-05-30       Impact factor: 11.454

Review 4.  Paracrine Factors Released by Stem Cells of Mesenchymal Origin and their Effects in Cardiovascular Disease: A Systematic Review of Pre-clinical Studies.

Authors:  Nishani S Mabotuwana; Lavinia Rech; Joyce Lim; Sean A Hardy; Lucy A Murtha; Peter P Rainer; Andrew J Boyle
Journal:  Stem Cell Rev Rep       Date:  2022-07-28       Impact factor: 6.692

5.  Mesenchymal stem cells are short-lived and do not migrate beyond the lungs after intravenous infusion.

Authors:  E Eggenhofer; V Benseler; A Kroemer; F C Popp; E K Geissler; H J Schlitt; C C Baan; M H Dahlke; M J Hoogduijn
Journal:  Front Immunol       Date:  2012-09-26       Impact factor: 7.561

6.  Mesenchymal stromal cell therapeutic potency is dependent upon viability, route of delivery, and immune match.

Authors:  Jayeeta Giri; Jacques Galipeau
Journal:  Blood Adv       Date:  2020-05-12

7.  The life and fate of mesenchymal stem cells.

Authors:  Elke Eggenhofer; Franka Luk; Marc H Dahlke; Martin J Hoogduijn
Journal:  Front Immunol       Date:  2014-05-19       Impact factor: 7.561

8.  Promotion of Survival and Engraftment of Transplanted Adipose Tissue-Derived Stromal and Vascular Cells by Overexpression of Manganese Superoxide Dismutase.

Authors:  Silvia Baldari; Giuliana Di Rocco; Angelo Trivisonno; Daniela Samengo; Giovambattista Pani; Gabriele Toietta
Journal:  Int J Mol Sci       Date:  2016-07-07       Impact factor: 5.923

9.  Mesenchymal stem cell-educated macrophages.

Authors:  Elke Eggenhofer; Martin J Hoogduijn
Journal:  Transplant Res       Date:  2012-09-28

Review 10.  Toward Development of iMesenchymal Stem Cells for Immunomodulatory Therapy.

Authors:  Samantha F H de Witte; Marcella Franquesa; Carla C Baan; Martin J Hoogduijn
Journal:  Front Immunol       Date:  2016-01-06       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.